한림대학교동탄성심병원

의료진 사진
유태석 교수
031-8086-2852
전문센터 소화기센터 로봇수술센터
진료과 외과 HOME

전문진료분야

췌장암, 간담췌암, 간이식, 로봇 및 복강경수술, 담낭절제술">췌장암, 간담췌암, 간이식, 로봇 및 복강경수술, 담낭절제술

전화 예약 1522-2500

(주간) 진료시간표 (2024-06-24 ~ 2024-06-29)

진료시간표
진료시간
오전 센터진료
오후 센터진료

학력

학력

한림대학교 의과대학 졸업

한림대학교 의학대학원 의학 석사

서울대학교 의학대학원 의학 박사

경력

경력

한림대학교의료원 수련/전공의 수료

~ 2012국립암센터 간암센터 공보의

~ 2014서울대학교병원 외과 간담췌 분과 전임의

한림대학교동탄성심병원 외과 간담췌분과 부교수

미국 클리브랜드 병원 간담췌,이식외과 연수(세계2위)

학회활동

학회활동

2019 ~ 2020대한로봇외과연구학회 정회원/기획위원

대한소화기학회 정회원

2013 ~ 2014대한간암학회 정회원/기획위원

대한이식학회 정회원

한국간담췌외과학회 정회원

대한외과학회 정회원

수상이력

수상이력

세계생체간이식학회 (ILDLT) 최우수 학술상 수상

아시아태평양소화기학회 (APDW) “Young Investigator Awards” 수상

한국간담췌외과학회경인지회 최우수논문상

세계간이식학회 (ILTS) “Travel Awards” 수상

세계간암학회 (ILCA) 최우수초록체택

국립 암 센터 우수연구자상 수상

춘계 한국간담췌외과학회 최우수발표상 (담도분야)

논문/저서

논문/저서
국내학회지 발표논문
1. Tae Suk You, M.D, Jin Cheol Jeong, M.D. and Jong Ho Yoon, M.D. Gasless Endoscopic Thyroidectomy via an Axillary Approach: Short-term Outcomes and Modifications of Approach Korean J Endocrine Surg 2007 Mar; 007(01): 28-33

국제학회지 발표논문
1. T. Yoo, WJ Lee, SM Woo, TH Kim, SS Han, SJ Park, SH Moon, KH Shin, SS Kim, EK Hong, DY Kim, JW Park. Pre-treatment CA 19-9 Level Indicates Tumor Response, Early Distant Metastasis, Overall Survival and Therapeutic Selection in Localized and Unresectable Pancreatic Cancer, Int. J. Radiation Oncology Biol. Phys., Vol. 81, No. 4, pp. e623–e630, 2011

2. T. Yoo, SH Kim, YK Kim, SY Cho, SJ Park. Low-dose Heparin Therapy During Living Donor Right Hepatectomy Is Associated With Few Side Effects and Does Not Increase Vascular Thrombosis in Liver Transplantation, Transplantation Proceedings., Vol. 45, pp. e222–224, 2013

3. T. Yoo, KC You, SG Park. How to single port laparoscopic cholecystectomy using LEAN BACK technique ANZ surg., Vol. 85, No. 4, pp. e284-5, 2015

4. TH Kim, SS Han, SJ Park, WJ Lee, SM Woo, T. Yoo, SH Moon, SH Kim, EK Hong, DY Kim, JW Park CA 19-9 level as indicator early distant metastasis and therapeutic selection in resected pancreatic cancer Int. J. Radiation Oncology Biol. Phys., Vol. 81, No. 5, pp. e743–e748, 2011

5. TH Kim, SS Han, SJ Park, WJ Lee, SM Woo, T. Yoo, SH Moon, SS Kim, SH Kim, EK Hong, DY Kim, JW Park Role of adjuvant chemotherapy for resected extrahepatic biliary tract cancer Int. J. Radiation Oncology Biol. Phys., Vol. 81, No. 5, pp. e853–e859, 2011

6. YK Kim, SH Kim, IS Moon, SS Han, SY Cho, T. Yoo, SJ Park. The effect of a positive T-lymphocytotoxic crossmatch on clinical outcomes in ALDLT Journal of the Korean surgical society., Vol. 84, No. 4, pp. e245-51, 2013

7. NJ Yi, KS Suh, SW Suh, YR Chang, G. Hong, Tae Yoo, HY Kim, MS Park, YR Choi, KW Lee, CW Jung, JH Lee, YJ Kim, JH Yoon, HS Lee. Excellent Outcome in 238 Consecutive Living Donor Liver Transplantations Using the Right Liver Graft in a Large Volume Single Center. World J Surg., Vol. 37 No. 6, pp. e1419-29, 2013

8. G. Hong, KW Lee, SW Suh, T. Yoo, HY Kim, MS Park, YR Choi, NJ Yi, KS Suh The Model for End-Stage Liver Disease Score-Based System Predicts Short Term Mortality Better Than the Current Child- Turcotte-Pugh Score-Based Allocation System during Waiting for Deceased Liver Transplantation. J Korean Med Sci 2013 Aug;28(8):1207-12

9. YR Choi, JY Choi, NJ Yi, KB Lee, S. Mori, G. Hong, HY Kim, MS Park, T. Yoo, SW Suh, HW Lee, KW Lee, KS Suh. Liver Transplantation for HBsAg Positive Recipients using Grafts from HBsAg Positive Deceased Donors. Transpl Int., Vol. 26, No. 121, pp. e173-83, 2013

10. MS Park, KW Lee, SW Suh, T. Yoo, YR Choi, HY Kim, G. Hong, NJ Yi, CH David Kwon, JW Joh, SK Lee, KS Suh. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation. Transplantation., Vol. 197 No. 1, pp. e71-7, 2014

11. HY Kim, KS Suh, KW Lee, NJ Yi, G. Hong, SW Suh, T. Yoo, MS Park, YR Choi, HW Lee. Long-Term Outcome of Laparoscopic Versus Open Liver Resection for Hepatocellular Carcinoma: A Case-Controlled Study with Propensity Score Matching. Surgical Endoscopy., Vol. 28, No. 3, pp. e950-960, 2014

12. YR Choi, JY Choi, NJ Yi, KB Lee, S. Mori, G. Hong, HY Kim, MS Park, T. Yoo, SW Suh, HW Lee, KW Lee, KS Suh. Living donor liver transplantation for an infant with osteogenesis imperfecta and intrahepatic cholestasis: report of a case. J Korean Med Sci., Vol. 29, No. 3, pp. e441-4 2014

13. Kim H, Lee K, Lee KW, Yi NJ, Lee HW, Hong G, Choi Y, You T, Suh SW, Jang JJ, Suh KS. Histologically proven nonalcoholic fatty liver disease and clinically related factors in recipients after liver transplantation. Clin Transplant., Vol. 28 No. 5, pp. e521-9, 2014

14. G. Hong, KW Lee, SW Suh, T. Yoo, HY Kim, MS Park, YR Choi, NJ Yi, KS Suh. Preoperative selective desensitization of live donor liver transplant recipients considering the degree of T lymphocyte cross-match titer, model for end-stage liver disease score, and graft liver volume. J Korean Med Sci., Vol. 29, No. 5, pp. e640-7, 2014

15. SW Suh, JM Lee, T. Yoo, YR Choi, NJ Yi, KW Lee, KS Suh. Prediction of aggressiveness in early-stage hepatocellular carcinoma for selection of surgical resection. J Hepatol., Vol. 60, No. 6, pp. e1219-24, 2014

16. SW Suh, JM Lee, T. Yoo, YR Choi, NJ Yi, KW Lee, KS Suh. Hepatic venous congestion in living donor grafts in liver transplantation: is there an effect on hepatocellular carcinoma recurrence? Liver Transpl., Vol. 20, No. 7, pp. e784-90, 2014

17. Tae Yoo, Sang-Jae Park, Sung-Sik Han, Seong Hoon Kim, Seung Duk Lee, Young-Kyu Kim, Tae Hyun Kim, Sang MyungWoo, Woo Jin Lee, and Eun Kyung Hong Postoperative CA19-9 Change Is a Useful Predictor of Intrahepatic Cholangiocarcinoma Survival following Liver Resection. Disease Markers Vol 2015

18. Geun Hong, Kyung-Suk Suh,, Suk-won Suh, Tae Yoo, Hyeyoung Kim, Min-Su Park, YoungRok Choi, Jin Chul Paeng, Nam-Joon Yi, Kwang-Woong Lee Preoperative alpha-fetoprotein and 18F-FDG PET predict tumor recurrence better than Milan criteria in living donor liver transplantation. Journal of Hepatology 2016

19. Tae Yoo, Kwang-Woong Lee, Nam-Joon Yi, Young Rok Choi, Hyeyoung Kim, Suk-Won Suh, Jae Hong Jeong, Jeong-Moo Lee, and Kyung-Suk Suh Peri-Transplant Change in AFP Level: A Useful Predictor of Hepatocellular Carcinoma Recurrence Following Liver Transplantation. J Korean Med Sci 2016; 31: 1049-1054

20. Choi, Y/ Lee, JM/ Yi, NJ/ Kim, H/ Park, MS/ Hong, G/ Yoo, T/ Suh, SW/ Lee, HW/ Lee, KW/ Suh, KS Heterogeneous living donor hepatic fat distribution on MRI chemical shift imaging Annals of Surgical Treatment and Research 2015;89(1):37-42

21. Yoo T, Park SJ et al. Proximal Resection Margins: More Prognostic than Distal Resection Margins in Patients Undergoing Hilar Cholangiocarcinoma Resection. See comment in PubMed Commons belowCancer Res Treat. 2017 Nov 16. Epub.

22. Tae Yoo, Won Tae Cho, Sung Min Kim, Is 8mm robotic port safe? A case of incision hernia after cholecystectomy using the Da vinci Xi system, Videosurgery Miniinv 2019; 14 (1): 137–14

23. Kim, J. Y., et al. (2019). "Prospective randomized clinical trial of uncomplicated right-sided colonic diverticulitis: antibiotics versus no antibiotics." Int J Colorectal Dis 34(8): 1413-1420.

24. Yoo, T., et al. (2020). "Impact of PNPLA3 (rs738409-G) polymorphism on post-transplant outcomes after liver transplantation for alcohol-related liver disease." Clin Transplant: e14011.

25. Chang W, Yoo T, Cho WT, Cho G. Comparing postoperative pain in various pressure pneumoperitoneum of laparoscopic cholecystectomy: a double-blind randomized controlled study. Ann Surg Treat Res. 2021 May;100(5):276-281.

26. Cho G, Yoo T, Chang W. Robotic cholecystectomy with a new port placement: Is it really beneficial? Asian J Surg. 2022 Aug;45(8):1542-1546.

27. Fujiki M, Pita A, Kusakabe J, Sasaki K, You T, Tuul M, Aucejo FN, Quintini C, Eghtesad B, Pinna A, Miller C, Hashimoto K, Kwon CHD. Left Lobe First With Purely Laparoscopic Approach: A Novel Strategy to Maximize Donor Safety in Adult Living Donor Liver Transplantation. Ann Surg. 2023 Oct 1;278(4):479-488.

28. Cho WT, Yoo T, Lee JM, Lee JW, Kim H, Lee JS, Han SH. Hepatitis B Virus DNA-Level Change is Associated With Tumor Recurrence in Patients With Resected Hepatitis B Virus Hepatocellular Carcinoma. J Surg Res. 2024 Mar;295:231-239.

언론보도